Rhodamine-123: Radioiodination and evaluation as an agent for imaging and radiotherapy of certain tumors
Rhodamine-123 (Rh-123) is a cationic lypophilic fluorescent dye which localizes in the mitochondria of living cells. The compound subsequently clears through normal cells but is selectively retained in carcinoma cells. As a result, the compound exhibits anticarcinoma activity both in vitro and in vivo. This high selectivity prompted us to evaluate Rhodamine-123 as an agent for imaging and radiotherapy. Accordingly in the present study Rh-123 was labeled with iodine-125 by chloramine-T. Tissue distributions were studied for C-3Hf/SED brown mice bearing 1 cm diameter implanted SCC VII carcinoma; CDF-1 mice with MB49 bladder carcinoma, nude mice with human CX-1 colon carcinoma and brown mice with murine mammary tumor. The results indicated that (i) initially the radioactivity was taken up by the liver (3.4%), thyroid (3.8%), kidney (2.3%) and tumor (0.8%); (ii) the radioactivity from all the normal tissues cleared within 24 hours but not from the tumors (iii) in tumors the radioactivity remained unchanged. This resulted in higher tumor/blood (1.2%) and tumor/muscle (4.2%) ratios which allows detection of the tumors by gamma camera imaging techniques. In the case of nude mice with human imaging CX-1 colon carcinoma and brown mice with murine mammary tumor the tumor/muscle ratios were interestingly much higher - 8.9% and 9.3%, respectively. These results clearly show that radioiodinated Rh-123 is a potential agent for imaging and radiotherapy of certain tumors.
- Research Organization:
- Massachusetts General Hospital, Boston, MA
- OSTI ID:
- 6852506
- Report Number(s):
- CONF-850611-; TRN: 87-011061
- Journal Information:
- J. Nucl. Med.; (United States), Vol. 26:5; Conference: 32. annual meeting of the Society of Nuclear Medicine, Houston, TX, USA, 2 Jun 1985
- Country of Publication:
- United States
- Language:
- English
Similar Records
Development and characterization of a monoclonal antibody to human embryonal carcinoma
SU-G-IeP4-11: Monitoring Tumor Growth in Subcutaneous Murine Tumor Model in Vivo: A Comparison Between MRI and Small Animal CT
Related Subjects
38 RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEAR CHEMISTRY
CARCINOMAS
RADIOTHERAPY
RHODAMINES
IODINATION
LABELLING
THERAPEUTIC USES
TISSUE DISTRIBUTION
BLADDER
BLOOD
CAMERAS
CHLORAMINES
DYES
GAMMA DETECTION
IMAGE PROCESSING
IN VITRO
IN VIVO
IODINE 125
KIDNEYS
LARGE INTESTINE
LIVER
MAMMARY GLANDS
MAN
MICE
MITOCHONDRIA
MUSCLES
RADIOACTIVITY
THYROID
AMINES
ANIMALS
BETA DECAY RADIOISOTOPES
BIOLOGICAL MATERIALS
BODY
BODY FLUIDS
CARBOXYLIC ACIDS
CELL CONSTITUENTS
CHEMICAL REACTIONS
DAYS LIVING RADIOISOTOPES
DETECTION
DIGESTIVE SYSTEM
DISEASES
DISTRIBUTION
ELECTRON CAPTURE RADIOISOTOPES
ENDOCRINE GLANDS
GASTROINTESTINAL TRACT
GLANDS
HALOGENATION
HETEROCYCLIC ACIDS
HETEROCYCLIC COMPOUNDS
INTERMEDIATE MASS NUCLEI
INTESTINES
IODINE ISOTOPES
ISOTOPES
MAMMALS
MATERIALS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANIC ACIDS
ORGANIC CHLORINE COMPOUNDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC OXYGEN COMPOUNDS
ORGANOIDS
ORGANS
PRIMATES
PROCESSING
RADIATION DETECTION
RADIOISOTOPES
RADIOLOGY
REAGENTS
RODENTS
THERAPY
URINARY TRACT
USES
VERTEBRATES
550604* - Medicine- Unsealed Radionuclides in Therapy- (1980-)
400700 - Radiochemistry & Nuclear Chemistry